Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-16-156661

Options or other derivatives

  • Chief Executive Officer acquired 310,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Quart Barry D · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-21 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +310,000 $13.00 2026-12-21 310,000 310,000 D
Loading xslF345X03/doc4.xml…